HEMLIBRA
150MG/ML INJ SOL 1X1ML
| SÚKL code | 0222796 |
|---|---|
| Name of the product | HEMLIBRA |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | HEMLIBRA |
| Supplement | 150MG/ML INJ SOL 1X1ML |
| Strenght | 150MG/ML |
| Pharmaceutical form | Solution for injection |
| Package | 1X1ML |
| Route | Subcutaneous use |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance | EMICIZUMAB (EMICIZUMABUM) |
| ATC group | B02BX06 |
| ATC group name | EMICIZUMAB |
Marketing authorisation information
| Registration Number | EU/1/18/1271/004 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Roche Registration GmbH, Grenzach-Wyhlen |
| MA Holder country | NĚMECKO |
cz